ClinConnect ClinConnect Logo
Search / Trial NCT05115799

Effects of a Manual Therapy Program to Reduce the Evolution Time of Axillary Web Syndrome

Launched by UNIVERSITY OF MALAGA · Oct 30, 2021

Trial Information

Current as of November 13, 2025

Recruiting

Keywords

Mastectomy Breast Cancer Lymphedema Kinesiology Applied Thrombosis Health Education Rehabilitation

ClinConnect Summary

This clinical trial is studying a manual therapy program designed to help patients who have developed Axillary Web Syndrome (AWS) after breast cancer surgery, specifically mastectomy. AWS can cause discomfort and limit movement in the arm, which may delay important cancer treatments like radiotherapy. The goal of the study is to see if specific exercises and stretching, led by a trained physiotherapist, can reduce the time AWS lasts, helping patients regain mobility and alleviate pain more quickly.

To be eligible for this trial, participants must be at least 18 years old, have undergone a mastectomy, and have a lymphatic thrombus (a blockage in the lymphatic system) in the arm on the same side as their surgery. The trial is open to all genders. Participants can expect to receive guided therapy to help with their symptoms, and their progress will be compared to a control group who will not receive the same treatment. This study could provide valuable insights into improving recovery for those affected by AWS.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient over 18 years old.
  • Mastectomized patients (either radical or conservative surgery).
  • Patient with lymphatic thrombus in the upper limb ipsilateral to the surgical intervention.
  • Exclusion Criteria:
  • Significant psychological alterations that would prevent the retrieval of the information necessary for the investigation.
  • Significant neurological alterations that would prevent the retrieval of the information necessary for the investigation.
  • Patients in a situation of legal dispute that would affect their intervention in this study.
  • Metastasis not treated with chemotherapy treatment.

About University Of Malaga

The University of Malaga, a leading academic institution in Spain, is committed to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise in various fields, including medicine, health sciences, and biotechnology, to conduct rigorous studies. The institution is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical trials, ultimately contributing to the development of groundbreaking therapies and enhancing the overall quality of healthcare.

Locations

Algeciras, Cádiz, Spain

Algeciras, Spain

Patients applied

0 patients applied

Trial Officials

Rocío Martín Valero, Physiothera

Study Director

Malaga U

María Jesús Viñolo Gil, Physiothera

Study Director

Cádiz U

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials